Nature of the Business and Basis of Presentation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Jan. 11, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net loss		$ 24,303	$ 30,070
Accumulated deficit		683,056		$ 658,753
Net cash used in operating activities		25,192	$ 27,995
Cash, cash equivalents and available-for-sale securities		$ 206,100
Common stock, shares authorized		60,000,000		60,000,000
Restricted cash		$ 1,800
At-the-Market Offering Sales Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock shares issued		350,664
Proceeds from issuance of common stock		$ 3,100
Private Placement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net proceeds from private placement	$ 103,700
Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock shares issued		350,664
Common Stock [Member] | At-the-Market Offering Sales Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock shares issued		350,664
Common Stock [Member] | Private Placement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock shares issued	16,973,103	16,973,103
Common stock issued price per share	$ 5.53
Pre Funded Warrants [Member] | Private Placement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Warrants outstanding	2,712,478
Common stock warrants exercise price per share	$ 5.529